Is there a role of isoproterenol testing in the electrical or concealed phase of arrhythmogenic right ventricular cardiomyopathy as a cardiologist’s nightmare?

EP Europace Journal

7 June 2018

Organised by:

Read full article

Contributors

Ozcan Ozeke

Ozcan Ozeke

Author

Ankara City Hospital Ankara , Turkiye

Serkan Cay

Serkan Cay

Author

Firat Ozcan

Firat Ozcan

Author

Serkan Topaloglu

Serkan Topaloglu

Author

Dursun Aras

Dursun Aras

Author

You may be interested in

Congress Presentation

Isoproterenol testing as a risk stratification tool in arrhythmogenic mitral valve prolapse

30 August 2025

Webinar

Challenging ECGs: distinguishing inherited arrhythmias from mimics

12 December 2025

Congress Presentation

Characterization and modelling of the abnormal electrophysiological response under beta-adrenergic stimulation in hypertrophic cardiomyopathy

23 April 2021

Congress Presentation

Mechanical and electrical uncoupling: the role of cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy. proof of concept.

9 March 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources